Vitamin Ventures

Vitamin Ventures targets seed and early-stage rounds, with a stated ability to follow on through growth stages. The firm's core activity centers on first-check writing for pre-Series A companies, where it can serve as a lead investor or co-lead in rounds that typical Western micro-VCs overlook. Growth-stage follow-ons are described as selective and reserved for top-performing portfolio companies.

Vitamin Ventures is structured as an asset manager rather than a single-family office, but its specific fund structure is not publicly detailed. The firm does not disclose its limited partners or capital base. Given the typical Moscow venture landscape, it likely operates as a closed pooled vehicle funded by a small group of local high-net-worth individuals rather than a broad institutional LP base.

The firm's disclosed focus on enterprise software, fintech, and AI/ML suggests it avoids hard-tech, biotech, consumer social, and capital-intensive physical-infrastructure plays. Vitamin's emphasis on B2B models with relatively short paths to revenue implies a negative screen on deep-science startups and sectors requiring heavy regulatory navigation beyond the fintech perimeter.

Vitamin Ventures likely relies on proprietary sourcing through Moscow's tech university networks, Skolkovo-affiliated incubators, and direct founder relationships. With no publicly advertised accelerator partnerships or scout programs, its deal flow is inferred to be relationship-driven, leveraging the dense technical talent pools around Moscow State University and the Yandex alumni ecosystem.

The geographic scope concentrates on Russia-born startups that serve the Russian and Eastern European markets, with expansion potential into Central Asia and the broader CIS region. The firm has not publicly indicated investment activity in Western Europe, North America, or Asia outside the former Soviet sphere.